A randomised controlled cross-over double-blind pilot study protocol on THC:CBD oromucosal spray efficacy as an add-on therapy for post-stroke spasticity

INTRODUCTION: Stroke is the most disabling neurological disorder and often causes spasticity. Transmucosal cannabinoids (tetrahydrocannabinol and cannabidiol (THC:CBD), Sativex) is currently available to treat spasticity-associated symptoms in patients with multiple sclerosis. Cannabinoids are being...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Marinelli, Lucio, Balestrino, Maurizio, Mori, Laura, Puce, Luca, Rosa, Gian Marco, Giorello, Laura, Currà, Antonio, Fattapposta, Francesco, Serrati, Carlo, Gandolfo, Carlo, Abbruzzese, Giovanni, Trompetto, Carlo
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2017
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5595207/
https://ncbi.nlm.nih.gov/pubmed/28882919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-016843
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados